Mass Mailings

In his letter in the Feb. 8, 1993, issue of The Scientist [page 12], Stephen R. Kaufman of the Medical Research Modernization Committee (an antivivisectionist animal rights organization) effectively admits that the animal "protection" movement does very little to help animals in any way with the tens of millions of contributions received from misguided supporters. His statement that "the movement...wastes much of its resources on mass mailings, and commits only a small fraction of its resou

Written byCharles Nicoll
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In his letter in the Feb. 8, 1993, issue of The Scientist [page 12], Stephen R. Kaufman of the Medical Research Modernization Committee (an antivivisectionist animal rights organization) effectively admits that the animal "protection" movement does very little to help animals in any way with the tens of millions of contributions received from misguided supporters.

His statement that "the movement...wastes much of its resources on mass mailings, and commits only a small fraction of its resources to animal research campaigns" has been amply documented by journalists. Syndicated columnist Jack Anderson has pointed out on a number of occasions that the animal "protection" movement is one of the best get-rich-quick rackets to come along in a long time. The Wall Street Journal (Oct. 29, 1990) and the official publication of the direct-marketing industry (Who's Mailing What?, July/August 1990) have reported that a large number of these "protection" organizations spend well over ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies